Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1247711

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Operating Theatres: Fire Prevention
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to classify surgical fires in operating theatres as never events.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	110129
answer	answer is ministerial correction date of answer 17/11/2020 answer text <p>There are no plans to classify surgical fires in operating theatres as Never Events.</p><p>Never Events are defined as serious incidents that are wholly preventable because guidance or safety recommendations that provide strong systemic protective barriers are available at a national level and should have been implemented by all healthcare providers.</p><p>Strong systemic protective barriers are defined as barriers that must be successful, reliable and comprehensive safeguards or remedies – such as a connector that stops a medicine being given by the wrong route or a window restrictor which prevents a window being opened wide enough for a patient to get through.</p><p>There is currently no national guidance or safety recommendations that provides such safeguards to prevent surgical fires in operating theatres. These types of incidents cannot therefore be defined as a Never Event.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 17/11/2020 15:33:59 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4131 label Biography information for Jim Shannon

1247718

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the covid-19 vaccine candidates for which the Government has provided funding, what the efficacy criteria are for each of those vaccine candidate trials; to what extent each of those efficacy criteria are required to be met in order that those vaccine candidate trials can be deemed by the Government to have achieved satisfactory outcomes; and by (a) what methods and (b) what number of people (i) in which locations and (ii) over what time periods those assessments on whether those safety criteria have been met are being made.
tabling member constituency	Yeovil
tabling member printed	Mr Marcus Fysh
uin	110169
answer	answer is ministerial correction date of answer 30/11/2020 answer text <p>There is broad agreement between international regulators on both the safety and the efficacy criteria that would be required for approval and authorisation of a COVID-19 vaccine. These criteria will apply to all COVID-19 vaccine candidates, irrespective of whether they receive funding from the United Kingdom Government.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) will perform the assessment of the quality, safety and efficacy data submitted by developers of COVID-19 vaccines and will seek the advice of its independent expert advisors on the Commission on Human Medicines.</p><p>No approval will be given for any COVID-19 vaccine without robust evidence of efficacy and safety. The MHRA has teams of assessors available to review the submissions.</p><p>To expedite the review of COVID-19 vaccine applications, developers of COVID-19 vaccines can submit their Marketing Authorisation Applications in the form of a rolling submissions and do not need to wait to have a complete data package before submission.</p><p>The time taken for MHRA’s review will depend on what data will be submitted and when.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 110170 question first answered 30/11/2020 12:04:29 answering member 4380 label Biography information for Jo Churchill
tabling member	4446 label Biography information for Mr Marcus Fysh

1247719

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the covid-19 vaccine candidates for which the Government has provided funding, what the safety criteria are for each of those vaccine candidate trials; to what extent each of those safety criteria are required to be met in order that those vaccine candidate trials can be deemed by the Government to have achieved satisfactory outcomes; and by (a) what methods and (b) what number of people (i) in which locations and (ii) over what time periods those assessments on whether those safety criteria have been met are being made.
tabling member constituency	Yeovil
tabling member printed	Mr Marcus Fysh
uin	110170
answer	answer is ministerial correction date of answer 30/11/2020 answer text <p>There is broad agreement between international regulators on both the safety and the efficacy criteria that would be required for approval and authorisation of a COVID-19 vaccine. These criteria will apply to all COVID-19 vaccine candidates, irrespective of whether they receive funding from the United Kingdom Government.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) will perform the assessment of the quality, safety and efficacy data submitted by developers of COVID-19 vaccines and will seek the advice of its independent expert advisors on the Commission on Human Medicines.</p><p>No approval will be given for any COVID-19 vaccine without robust evidence of efficacy and safety. The MHRA has teams of assessors available to review the submissions.</p><p>To expedite the review of COVID-19 vaccine applications, developers of COVID-19 vaccines can submit their Marketing Authorisation Applications in the form of a rolling submissions and do not need to wait to have a complete data package before submission.</p><p>The time taken for MHRA’s review will depend on what data will be submitted and when.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 110169 question first answered 30/11/2020 12:04:29 answering member 4380 label Biography information for Jo Churchill
tabling member	4446 label Biography information for Mr Marcus Fysh

1247720

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the covid-19 vaccine candidates for which the Government has provided funding, how much funding from the public purse has been allocated to the process of preparing each of those potential vaccines for (a) marketing, (b) manufacturing, (c) distribution and (d) administration.
tabling member constituency	Yeovil
tabling member printed	Mr Marcus Fysh
uin	110171
answer	answer is ministerial correction date of answer 18/11/2020 answer text <p>In terms of the six supply agreements that have and are being negotiated, these cannot be provided at this time due to commercial sensitivity. We are currently also unable to provide information on funding allocated to each potential vaccine for marketing, manufacturing, distribution and administration, as they have not yet been finalised.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 18/11/2020 12:59:55 answering member 4380 label Biography information for Jo Churchill
tabling member	4446 label Biography information for Mr Marcus Fysh

1247723

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment the Government has made of the potential effect of the (a) development and (b) authorisation of a covid-19 vaccine that doesn't prevent (i) transmission and (ii) fatalities on public confidence in (A) the Government response to covid-19, (B) public health programmes and (C) economic growth.
tabling member constituency	Yeovil
tabling member printed	Mr Marcus Fysh
uin	110174
answer	answer is ministerial correction date of answer 18/11/2020 answer text <p>A COVID-19 vaccine will only be deployed once it has been proven to be safe and effective through robust clinical trials and approved for use by the appropriate licensing authority. There are numerous potential vaccine candidates in development, which the United Kingdom will have access to. Once a vaccine is ready, it will be deployed to those most at risk, and then rolled out more widely. Regular testing of virus samples will be undertaken to assess any changes in the virus that may impact on vaccine effectiveness. Safe and effective vaccines rolled out to the population will form part of our overall recovery effort from the impact of this global pandemic.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 18/11/2020 12:53:10 answering member 4380 label Biography information for Jo Churchill
tabling member	4446 label Biography information for Mr Marcus Fysh

1247734

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to assess the effect of new research into the range and frequency of covid-19 symptoms on the adequacy of his guidance on the main symptoms of covid-19 which are used to recommend that individuals book a test for the virus; and how often that assessment takes place.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	110215
answer	answer is ministerial correction date of answer 05/02/2021 answer text <p>We will continue to review the evidence available to us through the Scientific Advisory Group for Emergencies, the Office for National Statistics and other sources and we continue to be guided by the science on our approach.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 05/02/2021 10:46:19 answering member 4527 label Biography information for Helen Whately
tabling member	4603 label Biography information for Preet Kaur Gill

1247742

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Gyms
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the evidential basis is for the decision of 31 October 2020 to close covid-19 secure gyms and sports facilities.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	110180
answer	answer is ministerial correction date of answer 10/11/2020 answer text <p>The Government’s response to the pandemic is guided by the science. Data and scientific advice informing the fight against COVID-19 are published on GOV.UK and specific relevant findings are shared in presentations accompanying significant policy announcements.</p><p>Unfortunately, we know that the virus spreads readily in indoor environments where members of different households and/or support bubbles spend time together. These restrictions do not single out restaurants, pubs or gyms but apply to a wide range of settings where the risk of transmission is high.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries grouped question UIN 110271 question first answered 10/11/2020 21:32:59 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4471 label Biography information for Rachael Maskell

1247743

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of enabling a family carer to support a relative with dementia in hospital during the covid-19 outbreak.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	110206
answer	answer is ministerial correction date of answer 27/11/2020 answer text <p>The health, safety and wellbeing of patients, communities, individuals and teams remain our absolute priority.</p><p>NHS England and NHS Improvement’s guidance ‘Visiting healthcare inpatient settings during the COVID-19 pandemic’ has consistently been that there should be reasonable adjustments to allow certain groups of people, including people with dementia, to have a family member or friend visit them if not being present would cause the patient to be distressed. This applies to all inpatient settings.</p><p> </p><p>In addition, to support the provision of person-centred care for older people, including those with dementia, local National Health Service trusts provide hospital passport templates that can be completed before attending hospital as an inpatient or outpatient. The hospital passport outlines, from the patient's perspective, what they would like staff to know about them and their care to help personalise their admission.</p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 27/11/2020 21:39:57 answering member 4362 label Biography information for Edward Argar
tabling member	4523 label Biography information for Catherine West

1247747

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Malnutrition: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of children who suffer from undernutrition in the UK.
tabling member constituency	Shipley
tabling member printed	Philip Davies
uin	110098
answer	answer is ministerial correction date of answer 18/11/2020 answer text <p>Estimates of the number of children who suffer from ‘undernutrition’ is not available.</p><p>The National Child Measurement Programme (NCMP) reports the number of children who are underweight in England. NCMP data for 2019/20 shows that the number of underweight children in England aged four to five years old is 3,771 out of 399,470 measured (0.9%) and the number of children aged 10-11 years old is 6,969 out of 491,138 measured (1.4%). This is stable compared with previous years and is below the 2% level expected in a healthy population. This data is available at the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/national-child-measurement-programme/2019-20-school-year" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/national-child-measurement-programme/2019-20-school-year</a></p><p> </p><p>Underweight may reflect undernutrition in a child but may also reflect a small build. A child of any weight status (underweight, healthy weight, overweight or obese) may suffer from undernutrition if a diet is lacking the nutrients required for healthy growth.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 18/11/2020 15:44:42 answering member 4380 label Biography information for Jo Churchill
tabling member	1565 label Biography information for Sir Philip Davies

1247748

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Malnutrition: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the reasons for undernutrition amongst children in the UK.
tabling member constituency	Shipley
tabling member printed	Philip Davies
uin	110099
answer	answer is ministerial correction date of answer 18/11/2020 answer text <p>The reasons for ‘undernutrition’, which is more generally referred to as malnutrition, are varied and complex. ‘Undernutrition’ amongst children can be both a cause and a consequence of ill health and may be linked to clinical, social and economic factors. It may develop as a result of limited access to food, a disorder or disease that results in a poor appetite, makes eating or absorbing food difficult or results in a greatly increased requirement for energy and nutrients.</p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 18/11/2020 12:50:08 answering member 4380 label Biography information for Jo Churchill
tabling member	1565 label Biography information for Sir Philip Davies